NFKB1 and chronic myelogenous leukemia, BCR-ABL1 positive: The NF-κB signaling pathway was found activated in MDS, AML, acute lymphoblastic leukemia (ALL), CML, CLL, multiple myeloma, and lymphoma cases before.